p21-Activated Kinases, antagonists & inhibitors
- Name
- p21-Activated Kinases, antagonists & inhibitors
- Accession Number
- DBCAT003150
- Description
Not Available
- Drugs
Drug Drug Description PF-03758309 PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors. - Drugs & Drug Targets
Drug Target Type PF-03758309 Serine/threonine-protein kinase PAK 4 target